NewsRoom Articles - Page 1307 of 1408

MondayMar 13, 2017 2:00 pm

Calgon Carbon Corp. (NYSE: CCC) Starts Presentation at 29th Annual ROTH Conference

Calgon Carbon (NYSE: CCC) provides innovative solutions, high quality products and reliable services designed to protect human health and the environment from harmful contaminants in water and air. As a manufacturer of activated carbon with broad capabilities in ultraviolet light disinfection, the company provides purification solutions for drinking water, wastewater, pollution abatement, and a variety of industrial and commercial manufacturing processes. Headquartered in Pittsburgh, Pennsylvania, the company operates 22 manufacturing, reactivation, innovation and equipment fabrication facilities in the U.S., Asia, and Europe. For more information, visit the company’s website at www.calgoncarbon.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication,…

MondayMar 13, 2017 2:00 pm

Frankly, Inc. (FLKKF) Starts Presentation at 29th Annual ROTH Conference

Frankly (OTC: FLKKF) has provided an integrated software platform for brands and media companies to create, distribute, analyze and monetize their content across all of their digital properties on web, mobile, and TV. The company’s customers include NBC, ABC, CBS and FOX affiliates, as well as other leading media organizations. Collectively, Frankly reaches nearly 60 million monthly users in the United States. For more information, visit the company’s website at www.franklyinc.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company…

MondayMar 13, 2017 2:00 pm

Cellectis SA (NASDAQ: CLLS) Starts Presentation at 29th Annual ROTH Conference

Cellectis (NASDAQ: CLLS) is a biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART). The company is engaged in developing a new generation of cancer therapies based on engineered T-cells. Cellectis capitalizes on its 17 years of experience in genome engineering based on its flagship TALEN® products and meganucleases as well as its pioneering electroporation PulseAgile technology, to create a new generation of immunotherapies. Using its life-science-focused, pioneering genome-engineering technologies, Cellectis’ goal is to create innovative products in multiple fields and with various target markets. For more information, visit the company’s website at www.cellectis.com. About NetworkNewsWire NetworkNewsWire…

MondayMar 13, 2017 2:00 pm

Lannett Company, Inc. (NYSE: LCI) Starts Presentation at 29th Annual ROTH Conference

Lannett Company (NYSE: LCI) develops, manufactures, packages, markets and distributes generic versions of brand pharmaceutical products in the United States. It offers solid oral, extended release, topical, nasal and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel and injectable dosages. The company provides its products for various medical indications comprising glaucoma, muscle relaxant, migraine, anesthetic, congestive heart failure, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, dryness of the mouth, gout, hypertension and gallstone. For more information, visit the company’s website at www.lannett.com. About…

MondayMar 13, 2017 2:00 pm

Kona Grill, Inc. (NASDAQ: KONA) Starts Presentation at 29th Annual ROTH Conference

Kona Grill (NASDAQ: KONA) features a global menu of contemporary American favorites, award-winning sushi, and specialty cocktails in an upscale casual atmosphere. Kona Grill owns and operates 45 restaurants, guided by a passion for quality food and exceptional service. Restaurants are located in 23 states and Puerto Rico. For more information, visit the company’s website at www.konagrill.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best…

MondayMar 13, 2017 2:00 pm

IRadimed Corp. (NASDAQ: IRMD) Starts Presentation at 29th Annual ROTH Conference

IRadimed (NASDAQ: IRMD) is engaged in the development of MRI compatible medical devices. The company provides non-magnetic intravenous (IV) infusion pump systems that are specifically designed to be safe for use during magnetic resonance imaging (MRI) procedures. The company’s patented MRidium® MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, uniquely-designed non-ferrous parts and other special features in order to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Additionally, the company’s 3880 MRI compatible patient vital signs monitoring system has been designed with non-magnetic components and other special features in…

MondayMar 13, 2017 2:00 pm

MacroGenics, Inc. (NASDAQ: MGNX) Starts Presentation at 29th Annual ROTH Conference

MacroGenics (NASDAQ: MGNX) is a biopharmaceutical company focused on discovering and developing antibody-based therapeutics for the treatment of cancer primarily by modulating the human immune system, as well as various autoimmune disorders and infectious diseases. Its advanced clinical product candidate is Margetuximab, a monoclonal antibody that is in Phase III clinical trial, which targets human epidermal growth factor receptor 2-expressing tumors, including certain types of breast and gastroesophageal cancers. The company also develops Enoblituzumab, an antibody that is in phase 1 clinical trial as monotherapy in multiple dose expansion cohorts; and MGD006, a DART molecule that targets CD123 and CD3.…

MondayMar 13, 2017 1:30 pm

Inphi Corp. (NYSE: IPHI) Starts Presentation at 29th Annual ROTH Conference

Inphi (NYSE: IPHI) is engaged in high-speed data movement. The company quickly moves big data throughout the globe between data centers, and inside data centers. Inphi's expertise in signal integrity results in reliable data delivery, at high speeds, over a variety of distances. As data volumes ramp exponentially due to video streaming, social media, cloud-based services, and wireless infrastructure, the need for speed has never been greater. Customers rely on Inphi's solutions to develop and build out the service provider and cloud infrastructures, and data centers of tomorrow. For more information, visit the company’s website at www.inphi.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

MondayMar 13, 2017 1:30 pm

Hudson Technologies, Inc. (NASDAQ: HDSN) Starts Presentation at 29th Annual ROTH Conference

Hudson Technologies (NASDAQ: HDSN) provides innovative solutions to recurring problems within the refrigeration industry. Hudson's proprietary RefrigerantSide® Services increase operating efficiency and energy savings, and remove moisture, oils and other contaminants frequently found in the refrigeration circuits of large comfort cooling and process refrigeration systems. Performed at a customer's site as an integral part of an effective scheduled maintenance program or in response to emergencies, RefrigerantSide® Services offer significant savings to customers due to their ability to be completed rapidly and at higher purity levels, and can be utilized while the customer's system continues to operate. In addition, the company sells refrigerants and provides…

MondayMar 13, 2017 1:30 pm

Kite Pharma, Inc. (NASDAQ: KITE) Starts Presentation at 29th Annual ROTH Conference

Kite Pharma (NASDAQ: KITE) is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies. The company aims to achieve its goal of providing rapid, long-term durable response and eliminating the burden of chronic care through the development of cancer immunotherapies. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information, visit the company’s website at www.kitepharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Calgon Carbon Corp. (NYSE: CCC) Starts Presentation at 29th Annual ROTH Conference

Frankly, Inc. (FLKKF) Starts Presentation at 29th Annual ROTH Conference

Cellectis SA (NASDAQ: CLLS) Starts Presentation at 29th Annual ROTH Conference

Lannett Company, Inc. (NYSE: LCI) Starts Presentation at 29th Annual ROTH Conference

Kona Grill, Inc. (NASDAQ: KONA) Starts Presentation at 29th Annual ROTH Conference

IRadimed Corp. (NASDAQ: IRMD) Starts Presentation at 29th Annual ROTH Conference

MacroGenics, Inc. (NASDAQ: MGNX) Starts Presentation at 29th Annual ROTH Conference

Inphi Corp. (NYSE: IPHI) Starts Presentation at 29th Annual ROTH Conference

Hudson Technologies, Inc. (NASDAQ: HDSN) Starts Presentation at 29th Annual ROTH Conference

Kite Pharma, Inc. (NASDAQ: KITE) Starts Presentation at 29th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search